Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
NEW YORK (Reuters Health) – Vaccinating pregnant women against influenza is a highly effective way of keeping their infants from being hospitalized with influenza in the first six…
NEW YORK (Reuters Health) – Initiating mediastinal nodal staging of suspected lung cancer with endosonography, followed by surgical staging (mediastinoscopy) if needed, improves the detection of metastases and…
NEW YORK (Reuters Health) – There appear to be several problems with the current clinical staging criteria for localized prostate cancer, according to a study published online today…
NEW YORK (Reuters Health) – Despite declining use, perineal radical prostatectomy (PRP) yields outcomes that are equal to, or better than, those of retropubic radical prostatectomy (RRP) and…
Join us for Meetings in Minutes – AHA Scientific Sessions 2010 – Extended Meeting Coverage. In this edition, we bring you extended coverage of the DEFINE trial, featuring…
NEW YORK (Reuters Health) – Outcomes of cryoablation of small renal masses are similar whether the procedure is performed surgically or percutaneously, according the results of a meta-analysis…
NEW YORK (Reuters Health) – In terms of overall survival, carboplatin plus the oral fluoropyrimidine derivative S-1 is as effective as carboplatin plus paclitaxel in chemotherapy-naive patients with…
Join us for Meetings in Minutes – AHA Scientific Sessions 2010 – Day 4. Our fourth and final daily wrap-up features highlights from the key late breaking trials,…
Join us for Meetings in Minutes – AHA Scientific Sessions 2010 – Day 3. Our third daily wrap-up features highlights from the key late breaking trials, and some…
Join us for Meetings in Minutes – AHA Scientific Sessions 2010 – Day 2. Our second daily wrap-up features highlights from the key late breaking trials, and some…
